Correction to: No evidence of lymphatic filariasis transmission in Bamako urban setting after three mass drug administration rounds

Affiliations

• ¹ Mali ‑ International Center of Excellence in Research (ICER‑Mali), University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.
• ² Dermatology Hospital of Bamako, Bamako, Mali.
• ³ Mali ‑ International Center of Excellence in Research (ICER‑Mali), University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali. mbsangare@icermali.org.
• ⁴ Interdisciplinary School of Health Sciences, Faculty of Health Sciences, University of Ottawa, Ottawa, ON, K1N 6N5, Canada. mbsangare@icermali.org.
• ⁵ National Lymphatic Filariasis Elimination Program, Ministry of Health and Public Hygiene, Bamako, Mali.
• ⁶ Centre Suisse de Recherche Scientifiques en Côte d'Ivoire, 01 BP 1303 Abidjan 01, Abidjan, Côte d'Ivoire.
• ⁷ UFR Science de la Nature, Université Nangui Abrogoua, 02 BP 801 Abidjan 01, Abidjan, Côte d'Ivoire.
• ⁸ School of Community Health Sciences, Njala University, Bo, Sierra Leone.
• ⁹ Centre for Neglected Tropical Diseases, Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool, UK.
• ¹⁰ Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK.
• ¹¹ Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.